OrbiMed Capital GP III LLC, Director at GLAUKOS Corp (GKOS), sold 382,538 shares at $45.98 ($17.3M) on 2017-03-10, disclosed to the SEC on 2017-03-14.
Open-market sale of $17.3M GKOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.98 | 915 | $42K | 0.2% |
| 2 | $45.98 | 96,113 | $4.4M | 25.5% |
| 3 | $45.30 | 1,998 | $91K | 0.5% |
| 4 | $45.30 | 208,712 | $9.5M | 54.5% |
| 5 | $46.13 | 7 | $323 | 0.0% |
| 6 | $46.13 | 693 |
| $32K |
| 0.2% |
| 7 | $44.54 | 73,401 | $3.3M | 18.9% |
| 8 | $44.54 | 699 | $31K | 0.2% |
| Total | $45.33 avg | 382,538 | $17.3M | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |